In medical terms, RA stands for rheumatoid arthritis, a chronic autoimmune disease in which the immune system mistakenly attacks the lining of the joints. It affects roughly 0.25% to 1% of the global population, predominantly women, and causes progressive joint damage if left untreated. Unlike osteoarthritis, which results from wear and tear on cartilage, RA is driven by immune system dysfunction that can also affect organs beyond the joints.
How RA Differs From Other Arthritis
The key distinction is that RA is an autoimmune condition. Your immune system, which normally fights infections, turns against your own joint tissue. It targets the synovial membrane, a thin lining inside each joint that produces lubricating fluid. In a healthy joint, this lining is just a few cells thick. In RA, it swells to 8 to 10 cells thick and becomes packed with inflammatory immune cells, including the same white blood cells your body uses to fight bacteria and viruses.
This thickened, inflamed tissue (called pannus) doesn’t just sit there. It actively invades and erodes the cartilage and bone it touches. Immune cells in the lining release signaling molecules that recruit even more inflammatory cells, trigger new blood vessel growth to feed the expanding tissue, and activate bone-destroying cells. The result is a self-reinforcing cycle of inflammation and joint damage that won’t resolve on its own.
Osteoarthritis, by contrast, involves cartilage gradually breaking down from mechanical stress. It tends to affect joints you’ve used heavily over a lifetime, like knees and hips. RA typically strikes the smaller joints first, especially the hands and feet, and it almost always affects both sides of the body symmetrically.
Common Symptoms
The hallmark of RA is joint pain, swelling, and stiffness that is worst in the morning. Morning stiffness in osteoarthritis usually fades within about 30 minutes. In RA, that stiffness often lasts much longer, sometimes hours, and gradually loosens up as you move through the day.
RA tends to begin in the small joints of the fingers, wrists, and toes before spreading to larger joints like the knees, ankles, elbows, and shoulders. The affected joints feel warm and puffy to the touch. Many people also experience fatigue, low-grade fever, and a general feeling of being unwell, especially during flares. Over time, untreated RA can cause visible joint deformity as cartilage and bone erode.
Effects Beyond the Joints
Because RA is a systemic disease, meaning it involves the whole immune system, it can affect organs far from the joints. People with RA face a higher risk of hardened and blocked arteries, as well as inflammation of the sac surrounding the heart. Lung tissue can become inflamed and scarred, leading to progressive shortness of breath. Dry eyes and dry mouth are also common, caused by a related condition called Sjögren’s syndrome that reduces moisture production.
Some people develop firm lumps called rheumatoid nodules, usually near pressure points like the elbows, though they can form anywhere in the body, including the heart and lungs. These complications are one reason early diagnosis and treatment matter so much.
How RA Is Diagnosed
There is no single test that confirms RA. Doctors use a scoring system that evaluates four factors: the number and location of swollen joints, blood test results, markers of inflammation, and how long symptoms have lasted. A score of 6 or higher out of 10 points to a definite RA diagnosis, but the process begins with a basic requirement: at least one joint must show visible swelling, and no other condition can better explain it.
Two blood tests play a central role. Rheumatoid factor (RF) is an antibody found in about 71% of people with RA, but it also shows up in people without the disease, so its specificity is only around 83%. A newer test for anti-CCP antibodies is more precise, with a specificity of about 94%, meaning a positive result is a strong signal. When both tests come back positive together, the specificity jumps to 96%, making a false positive very unlikely. However, roughly 20% to 30% of people with RA test negative on both markers, so a negative result does not rule the disease out. Doctors also check for elevated levels of inflammation markers in the blood, and imaging like X-rays or ultrasound can reveal early joint erosion.
Treatment Approach
The goal of RA treatment is to suppress the immune system’s attack on the joints, reduce inflammation, and prevent permanent damage. This is done primarily with a class of medications called disease-modifying antirheumatic drugs, or DMARDs. The most widely used is methotrexate, a traditional DMARD that has been a cornerstone of RA treatment for decades. It works by broadly dampening the overactive immune response.
When traditional DMARDs aren’t enough, doctors move to biologic therapies. These are newer, more targeted drugs that block specific parts of the immune system rather than suppressing it broadly. Some block a key inflammatory signaling molecule called TNF, which is one of the main drivers of joint destruction. Others target different immune cells or pathways. A related class of drugs called JAK inhibitors works similarly but is taken as a pill rather than an injection.
Early, aggressive treatment makes a significant difference. The inflammatory damage in RA begins early and accumulates, so starting DMARDs within months of symptom onset gives the best chance of preventing joint erosion and preserving function. Many people with well-managed RA achieve what doctors call remission or low disease activity, where symptoms are minimal and joint damage slows dramatically.
Who Gets RA
RA can develop at any age, but it most commonly appears between ages 30 and 60. Women are two to three times more likely to develop it than men. Smoking is the strongest known environmental risk factor, and having a family history of RA increases your likelihood as well. Hormonal factors likely play a role in the sex difference, as onset sometimes coincides with hormonal shifts like the postpartum period.
The disease is unpredictable in its course. Some people experience mild symptoms that respond well to the first medication they try. Others go through cycles of flares and remissions or develop progressive joint damage despite treatment. The variability is one reason RA requires ongoing monitoring, with regular blood work and imaging to track whether the disease is under control.